top of page
PREVIOUS THL SESSIONS
THL 2025
The third year of the Targeting Healthy Longevity series comprised five sessions. The first session introduced the THRIVE Act, legislation drafted by the Kitalys Institute to accelerate the approval of medical products that extend healthspan. Other sessions covered endpoints for chronic disease, FDA regulations applicable to emerging companies, and healthspan products both in development and currently on the market. The last session was the first THL event to take place both in-person (in New York City) and virtually.
Session 1 - Inaugural Session: Draft Healthspan Act: The THRIVE Act
Session 2 - Finding the Measure of Aging and Chronic Disease Risk
DEFRONZO PRESENTATION SKYLER PRESENTATION SHULMAN PRESENTATION
Session 3 - Regulatory Primer for LongBio Companies (Including applicants to XPRIZE Healthspan and ARPA-H PROSPR)
VIDEO TRANSCRIPT CHAT COMPANION ARTICLE
Session 4 - Inspired by the THRIVE Act: Featuring Four Promising Products for Extending Healthspan
VIDEO POST-SESSION VIDEO TRANSCRIPT CHAT
Session 5 - Pursuing Healthy Longevity for All: A Fireside Chat with William Haseltine and Lawrence Steinman, two iconic leaders in biomedical research and development
VIDEO PRE-SESSION VIDEO TRANSCRIPT
THL 2024
The second year of the Targeting Healthy Longevity series continued the rolling calendar format established in 2023. The first 2024 event featured the NIH director and NAM president, who discussed policy initiatives to extend healthspan. The second brought together experts in neurodegeneration, who described the spectrum of interventions currently available.
Session 1 - Targeting the Shared Roots of Cancer, Major Chronic Diseases and Age-Related Disabilities to Increase Healthy Longevity
FIRESIDE CHAT VIDEO ROUNDTABLE VIDEO PRE-SESSION VIDEO
FIRESIDE CHAT TRANSCRIPT ROUNDTABLE TRANSCRIPT PRE-SESSION TRANSCRIPT
Session 2 - Novel Interventions for Preempting Neurodegeneration
VIDEO PRE-SESSION VIDEO TRANSCRIPT CHAT
THL 2023
Targeting Healthy Longevity began in 2023. THL sessions were spread throughout the year and included an interview with the FDA Commissioner; discussions of chronic disease prevention and loneliness; and an overview of the COSMOS trial, which evaluated the impact of cocoa extract on cardiovascular health.
Session 1 - FDA Commissioner on Healthy Longevity
Session 2 - Opportunities & Challenges for Preempting Chronic Diseases Before They Start
Session 3 - Loneliness: The Hidden Public Health Crisis
Session 4 - The COSMOS Trials: Large Randomized Controlled Trials Supporting Supplements for Healthy Longevity
bottom of page